Amit Sachdev Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Amit Sachdev.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Amit Sachdev for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 238.33 | 540 | 128,698 | 32,915 | 33.5 K to 32.9 K (-1.61 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 236.63 | 180 | 42,593 | 33,455 | 33.6 K to 33.5 K (-0.54 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 235.75 | 360 | 84,870 | 33,635 | 34 K to 33.6 K (-1.06 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 234.56 | 533 | 125,020 | 33,995 | 34.5 K to 34 K (-1.54 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 233.18 | 90 | 20,986 | 34,528 | 34.6 K to 34.5 K (-0.26 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 232.62 | 450 | 104,679 | 34,618 | 35.1 K to 34.6 K (-1.28 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.98 | 270 | 62,365 | 35,068 | 35.3 K to 35.1 K (-0.76 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.00 | 953 | 219,190 | 35,338 | 36.3 K to 35.3 K (-2.63 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 239.23 | 3,156 | 755,010 | 36,291 | 39.4 K to 36.3 K (-8.00 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 245.82 | 249 | 61,209 | 39,447 | 39.7 K to 39.4 K (-0.63 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 245.15 | 720 | 176,508 | 39,696 | 40.4 K to 39.7 K (-1.78 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 244.08 | 540 | 131,803 | 40,416 | 41 K to 40.4 K (-1.32 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 242.85 | 1,260 | 305,991 | 40,956 | 42.2 K to 41 K (-2.98 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 242.04 | 720 | 174,269 | 42,216 | 42.9 K to 42.2 K (-1.68 %) |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 241.50 | 3,262 | 787,773 | 42,936 | 46.2 K to 42.9 K (-7.06 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 248.73 | 400 | 99,492 | 46,198 | 46.6 K to 46.2 K (-0.86 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 247.98 | 2,103 | 521,502 | 46,598 | 48.7 K to 46.6 K (-4.32 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 246.88 | 1,821 | 449,568 | 48,701 | 50.5 K to 48.7 K (-3.60 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 245.99 | 4,320 | 1,062,677 | 50,522 | 54.8 K to 50.5 K (-7.88 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 245.05 | 3,426 | 839,541 | 54,842 | 58.3 K to 54.8 K (-5.88 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 243.53 | 1,000 | 243,530 | 58,268 | 59.3 K to 58.3 K (-1.69 %) |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 240.95 | 12,215 | 2,943,204 | 59,268 | 71.5 K to 59.3 K (-17.09 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,323 | 0 | 71,483 | 61.2 K to 71.5 K (+16.88 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 9,800 | 0 | 61,160 | 51.4 K to 61.2 K (+19.08 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 15,170 | 0 | 51,360 | 36.2 K to 51.4 K (+41.92 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,941 | 167,935 | 7,767 | |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 91.05 | 2,156 | 196,304 | 0 | |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 232.87 | 400 | 93,148 | 36,190 | 36.6 K to 36.2 K (-1.09 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 231.92 | 1,177 | 272,970 | 36,590 | 37.8 K to 36.6 K (-3.12 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 231.25 | 1,306 | 302,013 | 37,767 | 39.1 K to 37.8 K (-3.34 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.07 | 714 | 164,270 | 39,073 | 39.8 K to 39.1 K (-1.79 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 228.89 | 500 | 114,445 | 39,787 | 40.3 K to 39.8 K (-1.24 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,941 | 167,935 | 40,287 | 38.3 K to 40.3 K (+5.06 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 91.05 | 2,156 | 196,304 | 38,346 | 36.2 K to 38.3 K (+5.96 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,941 | 167,935 | 7,767 | |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 91.05 | 2,156 | 196,304 | 0 | |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 232.87 | 400 | 93,148 | 36,190 | 36.6 K to 36.2 K (-1.09 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 231.92 | 1,177 | 272,970 | 36,590 | 37.8 K to 36.6 K (-3.12 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 231.25 | 1,306 | 302,013 | 37,767 | 39.1 K to 37.8 K (-3.34 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.07 | 714 | 164,270 | 39,073 | 39.8 K to 39.1 K (-1.79 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 228.89 | 500 | 114,445 | 39,787 | 40.3 K to 39.8 K (-1.24 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,941 | 167,935 | 40,287 | 38.3 K to 40.3 K (+5.06 %) |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 91.05 | 2,156 | 196,304 | 38,346 | 36.2 K to 38.3 K (+5.96 %) |